Cell primitive-based biomimetic nanomaterials for Alzheimer's disease targeting and therapy

Alzheimer's disease (AD) is a progressive neurodegenerative disorder, which is not just confined to the older population. Although developments have been made in AD treatment, various limitations remain to be addressed. These are partly contributed by biological hurdles, such as the blood–brain...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Tong, Liu, Yan, He, Bin, Gong, Baofeng, Chu, Jianjian, Gao, Chao, Liang, Wendanqi, Hao, Mengqi, Sun, Wenjing, Zhuang, Jianhua, Gao, Jie, Yin, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495673/
https://www.ncbi.nlm.nih.gov/pubmed/37706205
http://dx.doi.org/10.1016/j.mtbio.2023.100789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495673/
https://www.ncbi.nlm.nih.gov/pubmed/37706205
http://dx.doi.org/10.1016/j.mtbio.2023.100789

Ejemplares similares